glp-1 augusta GLP-1 | Summary
Description
Pack GLP1
Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)
It doesnt affect sugar glucose levels so you can enjoy high sweetness treats with overall less worries
They are usually benign
These are real e...
